Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients

Derek Culnan, Karel D. Capek, Charles Voigt, Kuzhali Muthumalaiappan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Severely burned patients suffer significant hematologic pathologies. Anemia develops from burn excisions and the anemia of critical illness. Fluid shifts, resuscitation, and factor consumption can cause significant coagulopathy. Transfusion of red blood cells to treat anemia, plasma to treat coagulopathy, and other blood products are critical to burn management. Critical illness, injury, immobilization, and other factors create a hypercoagulable state requiring venothromboembolic prophylaxis. Hematopoietic changes reduce red blood cell generation as well as affecting downstream immunologic function. Facile management of these hematologic pathologies is essential to the medical and surgical management of burn patients.

Original languageEnglish (US)
Title of host publicationTotal Burn Care
Subtitle of host publicationFifth Edition
PublisherElsevier Inc.
Pages236-247.e6
ISBN (Electronic)9780323497428
ISBN (Print)9780323476614
DOIs
StatePublished - Nov 30 2017

Fingerprint

Transfusion Medicine
Hematology
Hemostasis
Anemia
Critical Illness
Fluid Shifts
Pathology
Erythrocyte Transfusion
Resuscitation
Immobilization
Erythrocytes
Wounds and Injuries

Keywords

  • Anemia
  • Anticoagulation
  • Coagulation
  • Hematopoiesis
  • Hemostasis
  • Heparin
  • Stem cells
  • Thromboelastogram/TEG
  • Transfusion
  • VTE

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Culnan, D., Capek, K. D., Voigt, C., & Muthumalaiappan, K. (2017). Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. In Total Burn Care: Fifth Edition (pp. 236-247.e6). Elsevier Inc.. https://doi.org/10.1016/B978-0-323-47661-4.00022-8

Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. / Culnan, Derek; Capek, Karel D.; Voigt, Charles; Muthumalaiappan, Kuzhali.

Total Burn Care: Fifth Edition. Elsevier Inc., 2017. p. 236-247.e6.

Research output: Chapter in Book/Report/Conference proceedingChapter

Culnan, D, Capek, KD, Voigt, C & Muthumalaiappan, K 2017, Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. in Total Burn Care: Fifth Edition. Elsevier Inc., pp. 236-247.e6. https://doi.org/10.1016/B978-0-323-47661-4.00022-8
Culnan D, Capek KD, Voigt C, Muthumalaiappan K. Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. In Total Burn Care: Fifth Edition. Elsevier Inc. 2017. p. 236-247.e6 https://doi.org/10.1016/B978-0-323-47661-4.00022-8
Culnan, Derek ; Capek, Karel D. ; Voigt, Charles ; Muthumalaiappan, Kuzhali. / Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. Total Burn Care: Fifth Edition. Elsevier Inc., 2017. pp. 236-247.e6
@inbook{e2eb285619984daa88e3cff6fea65da3,
title = "Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients",
abstract = "Severely burned patients suffer significant hematologic pathologies. Anemia develops from burn excisions and the anemia of critical illness. Fluid shifts, resuscitation, and factor consumption can cause significant coagulopathy. Transfusion of red blood cells to treat anemia, plasma to treat coagulopathy, and other blood products are critical to burn management. Critical illness, injury, immobilization, and other factors create a hypercoagulable state requiring venothromboembolic prophylaxis. Hematopoietic changes reduce red blood cell generation as well as affecting downstream immunologic function. Facile management of these hematologic pathologies is essential to the medical and surgical management of burn patients.",
keywords = "Anemia, Anticoagulation, Coagulation, Hematopoiesis, Hemostasis, Heparin, Stem cells, Thromboelastogram/TEG, Transfusion, VTE",
author = "Derek Culnan and Capek, {Karel D.} and Charles Voigt and Kuzhali Muthumalaiappan",
year = "2017",
month = "11",
day = "30",
doi = "10.1016/B978-0-323-47661-4.00022-8",
language = "English (US)",
isbn = "9780323476614",
pages = "236--247.e6",
booktitle = "Total Burn Care",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients

AU - Culnan, Derek

AU - Capek, Karel D.

AU - Voigt, Charles

AU - Muthumalaiappan, Kuzhali

PY - 2017/11/30

Y1 - 2017/11/30

N2 - Severely burned patients suffer significant hematologic pathologies. Anemia develops from burn excisions and the anemia of critical illness. Fluid shifts, resuscitation, and factor consumption can cause significant coagulopathy. Transfusion of red blood cells to treat anemia, plasma to treat coagulopathy, and other blood products are critical to burn management. Critical illness, injury, immobilization, and other factors create a hypercoagulable state requiring venothromboembolic prophylaxis. Hematopoietic changes reduce red blood cell generation as well as affecting downstream immunologic function. Facile management of these hematologic pathologies is essential to the medical and surgical management of burn patients.

AB - Severely burned patients suffer significant hematologic pathologies. Anemia develops from burn excisions and the anemia of critical illness. Fluid shifts, resuscitation, and factor consumption can cause significant coagulopathy. Transfusion of red blood cells to treat anemia, plasma to treat coagulopathy, and other blood products are critical to burn management. Critical illness, injury, immobilization, and other factors create a hypercoagulable state requiring venothromboembolic prophylaxis. Hematopoietic changes reduce red blood cell generation as well as affecting downstream immunologic function. Facile management of these hematologic pathologies is essential to the medical and surgical management of burn patients.

KW - Anemia

KW - Anticoagulation

KW - Coagulation

KW - Hematopoiesis

KW - Hemostasis

KW - Heparin

KW - Stem cells

KW - Thromboelastogram/TEG

KW - Transfusion

KW - VTE

UR - http://www.scopus.com/inward/record.url?scp=85054446869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054446869&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-47661-4.00022-8

DO - 10.1016/B978-0-323-47661-4.00022-8

M3 - Chapter

AN - SCOPUS:85054446869

SN - 9780323476614

SP - 236-247.e6

BT - Total Burn Care

PB - Elsevier Inc.

ER -